Alternative to Rituximab therapy for a patient with ankylosing spondylitis who was unable to continue anti-TNF therapy

Eri Katsuyama, Hiroshi Wakabayashi, Kenei Sada, Sumie Hiramatsu, Yoshia Miyawaki, Michiko Morishita, Keiji Ohashi, Haruki Watanabe, Takayuki Katsuyama, Sonia Zeggar, Mariko Narazaki, Noriko Tatebe, Katsue S. Watanabe, Tomoko Kawabata, Jun Wada

Research output: Contribution to journalArticle

Abstract

We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS). Infliximab (IFX) markedly improved the axial symptom but was discontinued due to the side effect of peripheral neuropathy. Switching from IFX to etanercept worsened the side effect. Rituximab (RTX) administration elicited a good response without side effects. RTX might be a suitable option for AS therapy when TNF inhibitors are difficult to use.

Original languageEnglish
Pages (from-to)445-448
Number of pages4
JournalActa Medica Okayama
Volume71
Issue number5
Publication statusPublished - 2017

Fingerprint

Ankylosing Spondylitis
Sacroiliitis
Bamboo
Peripheral Nervous System Diseases
Spine
Therapeutics
Rituximab
Infliximab
Etanercept

Keywords

  • Ankylosing spondylitis
  • Rituximab
  • Treatment

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Alternative to Rituximab therapy for a patient with ankylosing spondylitis who was unable to continue anti-TNF therapy. / Katsuyama, Eri; Wakabayashi, Hiroshi; Sada, Kenei; Hiramatsu, Sumie; Miyawaki, Yoshia; Morishita, Michiko; Ohashi, Keiji; Watanabe, Haruki; Katsuyama, Takayuki; Zeggar, Sonia; Narazaki, Mariko; Tatebe, Noriko; Watanabe, Katsue S.; Kawabata, Tomoko; Wada, Jun.

In: Acta Medica Okayama, Vol. 71, No. 5, 2017, p. 445-448.

Research output: Contribution to journalArticle

Katsuyama, E, Wakabayashi, H, Sada, K, Hiramatsu, S, Miyawaki, Y, Morishita, M, Ohashi, K, Watanabe, H, Katsuyama, T, Zeggar, S, Narazaki, M, Tatebe, N, Watanabe, KS, Kawabata, T & Wada, J 2017, 'Alternative to Rituximab therapy for a patient with ankylosing spondylitis who was unable to continue anti-TNF therapy', Acta Medica Okayama, vol. 71, no. 5, pp. 445-448.
Katsuyama, Eri ; Wakabayashi, Hiroshi ; Sada, Kenei ; Hiramatsu, Sumie ; Miyawaki, Yoshia ; Morishita, Michiko ; Ohashi, Keiji ; Watanabe, Haruki ; Katsuyama, Takayuki ; Zeggar, Sonia ; Narazaki, Mariko ; Tatebe, Noriko ; Watanabe, Katsue S. ; Kawabata, Tomoko ; Wada, Jun. / Alternative to Rituximab therapy for a patient with ankylosing spondylitis who was unable to continue anti-TNF therapy. In: Acta Medica Okayama. 2017 ; Vol. 71, No. 5. pp. 445-448.
@article{46a086e6858743d8bb05d0e3520ece3f,
title = "Alternative to Rituximab therapy for a patient with ankylosing spondylitis who was unable to continue anti-TNF therapy",
abstract = "We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS). Infliximab (IFX) markedly improved the axial symptom but was discontinued due to the side effect of peripheral neuropathy. Switching from IFX to etanercept worsened the side effect. Rituximab (RTX) administration elicited a good response without side effects. RTX might be a suitable option for AS therapy when TNF inhibitors are difficult to use.",
keywords = "Ankylosing spondylitis, Rituximab, Treatment",
author = "Eri Katsuyama and Hiroshi Wakabayashi and Kenei Sada and Sumie Hiramatsu and Yoshia Miyawaki and Michiko Morishita and Keiji Ohashi and Haruki Watanabe and Takayuki Katsuyama and Sonia Zeggar and Mariko Narazaki and Noriko Tatebe and Watanabe, {Katsue S.} and Tomoko Kawabata and Jun Wada",
year = "2017",
language = "English",
volume = "71",
pages = "445--448",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "5",

}

TY - JOUR

T1 - Alternative to Rituximab therapy for a patient with ankylosing spondylitis who was unable to continue anti-TNF therapy

AU - Katsuyama, Eri

AU - Wakabayashi, Hiroshi

AU - Sada, Kenei

AU - Hiramatsu, Sumie

AU - Miyawaki, Yoshia

AU - Morishita, Michiko

AU - Ohashi, Keiji

AU - Watanabe, Haruki

AU - Katsuyama, Takayuki

AU - Zeggar, Sonia

AU - Narazaki, Mariko

AU - Tatebe, Noriko

AU - Watanabe, Katsue S.

AU - Kawabata, Tomoko

AU - Wada, Jun

PY - 2017

Y1 - 2017

N2 - We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS). Infliximab (IFX) markedly improved the axial symptom but was discontinued due to the side effect of peripheral neuropathy. Switching from IFX to etanercept worsened the side effect. Rituximab (RTX) administration elicited a good response without side effects. RTX might be a suitable option for AS therapy when TNF inhibitors are difficult to use.

AB - We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS). Infliximab (IFX) markedly improved the axial symptom but was discontinued due to the side effect of peripheral neuropathy. Switching from IFX to etanercept worsened the side effect. Rituximab (RTX) administration elicited a good response without side effects. RTX might be a suitable option for AS therapy when TNF inhibitors are difficult to use.

KW - Ankylosing spondylitis

KW - Rituximab

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85031104408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031104408&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 445

EP - 448

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 5

ER -